---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047553"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2024-11-25T23:59:59+00:00"
generated_at: "2026-05-29T19:21:34.653490+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# QHSLab reports Oct sales up 110% to $225k; APA abstracts accepted for 2025

## Summary
- October 2024 unaudited sales ~$225,000, a 110% increase YoY; annualized run rate $2.7M.
- Two research abstracts accepted for presentation at 2025 APA Annual Meeting in Los Angeles.
- DMAR study (allergic rhinitis) reached second milestone; participant recruitment exceeded projections.
- Company highlights reductions in symptom severity and improved quality of life in mental health studies.

## SEC filing metadata
- accession: 0001493152-24-047553
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2024-11-25T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315224047553/0001493152-24-047553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315224047553/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047553
- JSON: https://secwatch.observer/filing/0001493152-24-047553.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.